Voyager Therapeutics Inc (VYGR)
5.43
+0.07
(+1.31%)
USD |
NASDAQ |
Nov 21, 16:00
5.69
+0.26
(+4.79%)
Pre-Market: 09:07
Voyager Therapeutics Total Assets (Quarterly): 426.04M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 426.04M |
| June 30, 2024 | 436.22M |
| March 31, 2024 | 469.59M |
| December 31, 2023 | 351.28M |
| September 30, 2023 | 294.65M |
| June 30, 2023 | 315.54M |
| March 31, 2023 | 336.29M |
| December 31, 2022 | 159.36M |
| September 30, 2022 | 182.48M |
| June 30, 2022 | 188.60M |
| March 31, 2022 | 224.18M |
| December 31, 2021 | 193.86M |
| September 30, 2021 | 184.77M |
| June 30, 2021 | 208.73M |
| March 31, 2021 | 237.72M |
| December 31, 2020 | 261.58M |
| September 30, 2020 | 269.76M |
| June 30, 2020 | 297.46M |
| March 31, 2020 | 322.61M |
| December 31, 2019 | 354.76M |
| Date | Value |
|---|---|
| September 30, 2019 | 376.22M |
| June 30, 2019 | 388.59M |
| March 31, 2019 | 411.35M |
| December 31, 2018 | 177.03M |
| September 30, 2018 | 197.06M |
| June 30, 2018 | 214.66M |
| March 31, 2018 | 235.03M |
| December 31, 2017 | 184.48M |
| September 30, 2017 | 140.92M |
| June 30, 2017 | 158.41M |
| March 31, 2017 | 175.09M |
| December 31, 2016 | 189.57M |
| September 30, 2016 | 201.98M |
| June 30, 2016 | 209.82M |
| March 31, 2016 | 219.98M |
| December 31, 2015 | 229.46M |
| September 30, 2015 | 166.44M |
| June 30, 2015 | 173.76M |
| December 31, 2014 | 11.50M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
159.36M
Minimum
Dec 2022
469.59M
Maximum
Mar 2024
285.77M
Average
282.20M
Median
Total Assets (Quarterly) Benchmarks
| Rhythm Pharmaceuticals Inc | 363.57M |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
| Theriva Biologics Inc | 40.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 95.73M |
| Shareholders Equity (Quarterly) | 330.31M |
| Current Ratio | 8.447 |